Hair follicle dermal stem cells and skin‐derived precursor cells: Exciting tools for endogenous and exogenous therapies

    June 2017 in “Experimental Dermatology
    Natacha A. Agabalyan, Nicole L. Rosin, Waleed Rahmani, Jeff Biernaskie
    Image of study
    TLDR Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.
    The document from 2017 explores the potential of hair follicle dermal stem cells (hfDSCs) and skin-derived precursor cells (SKPs) in hair follicle regeneration and their use in therapies for hair loss and skin diseases. It highlights the role of hfDSCs in replenishing the dermal papilla (DP) and connective tissue sheath (CTS), which are crucial for hair growth, and suggests that these cells could be used to repopulate the DP to treat hair loss. The authors also discuss the importance of the transcription factor Sox2 in maintaining hfDSC plasticity and call for a redefinition of SKPs based on functional characteristics. They conclude that hfDSCs and SKPs hold promise for restorative therapies, particularly hfDSCs for their unique ability to reconstitute HF mesenchyme and induce hair growth, but emphasize the need for further research to advance clinical applications.
    View this study on onlinelibrary.wiley.com →

    Cited in this study

    Related